Delivery Order SPE2DB22D3016-SPE2DB25FBAK8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Botox 100 Unit Vials with a ceiling value of $10,336.32. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, reflecting open competition among eligible vendors. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of BOTOX 100 unit vials with a ceiling value of $8,613.60. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by August 20, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of BOTOX 100 Unit Vials with a ceiling value of $4,306.80. This competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of June 26, 2025, and carries no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's established role as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of BOTOX 100 Unit Vials with a ceiling value of $10,336.32. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of BOTOX 100 unit vials with a ceiling value of $5,168.16. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is set for ultimate completion by June 17, 2025, with performance to occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Botox 200 Unit Vials with a ceiling value of $25,643.70 and firm fixed pricing. This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 17, 2025, and performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $20,514.96 to AmerisourceBergen Drug Corp for BOTOX 200 unit vials on July 15, 2025, with an ultimate completion date of August 5, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Botox 100 unit vials with a ceiling value of $2,584.08. This is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a non-competitive set-aside award. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. As a child delivery order, this award falls under a larger contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of BOTOX Cosmetic 100 Unit Vials, valued at $3,574.80 with a completion date of September 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Botox 100 unit vials valued at $10,336.32. This firm fixed-price delivery order, with a completion date of August 11, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract was awarded without a set-aside designation, indicating open competition. This delivery order is a child contract issued under AmerisourceBergen...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBAK8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of BOTOX 100 Unit Vials with a ceiling value of $43,068.00. This firm fixed-price delivery order, with an ultimate completion date of July 18, 2025, represents a competitive award with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's extensive pharmaceutical distribution infrastructure to support federal medical procurement needs. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications and medical commodities to support military healthcare programs and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. The delivery order represents a discrete fulfillment under this overarching pharmaceutical supply agreement designed to meet specialized federal medical requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.1k | 6/26/25 |